Elliott Crouser, MD
Critical Care Medicine · Columbus, OHNPI 1578576922
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,355 of the $16,320 with a category attached, or 81.8%. 5 manufacturers reported payments, led by Boehringer Ingelheim at 58.5% of the total. Among critical care medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $741.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$10K
- Merck$6K
- Beckman Coulter, Inc.$539
- Mallinckrodt Enterprises LLC$90
- Cepheid$43
Across 13 payments — averaging $59,127 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beckman Coulter, Inc.$766K
- E.r. Squibb & Sons, L.L.C.$3K
What the payments were for
- Consulting fees$13,35582%
- Travel & lodging$2,27714%
- Food & beverage$6884%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 6 | $9,546 |
| Merck | 8 | $6,102 |
| Beckman Coulter, Inc. | 6 | $539 |
| Mallinckrodt Enterprises LLC | 1 | $90 |
| Cepheid | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,320 in reported general payments places this provider in the 95th percentile of 285 critical care medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mycophenolate Mofetil | 75 | $10,532 |
| Advair HfaFluticasone Propion/Salmeterol | 24 | $9,365 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,070 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,156 |
| MethotrexateMethotrexate Sodium | 61 | $1,588 |
| Hydroxychloroquine Sulfate | 15 | $1,188 |
| Azathioprine | 23 | $966 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $683 |
| Prednisone | 123 | $603 |
| Azelastine Hcl | 11 | $140 |
| Spironolactone | 13 | $131 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $87 |
| Furosemide | 14 | $10 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Columbus
- Nicholas PastisColumbus$145K
- Michael EssandohColumbus$135K
- Kari GorderColumbus$20K
- Shailesh PintoColumbus$7K
- John ChristmanColumbus$5K
- Jennifer JamesColumbus$2K
- Jared CollinsColumbus$1K
- Neal ChaissonCleveland$428K
- Robert SchilzCleveland$356K
- Chiedozie UdehCleveland$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.